SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-297583
Filing Date
2014-08-06
Accepted
2014-08-06 12:02:59
Documents
5
Period of Report
2014-08-05
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d768648d8k.htm 8-K 19675
2 EX-3.1 d768648dex31.htm EX-3.1 19914
3 EX-3.2 d768648dex32.htm EX-3.2 155492
4 EX-99.1 d768648dex991.htm EX-99.1 6031
5 GRAPHIC g768648g95m11.jpg GRAPHIC 5717
  Complete submission text file 0001193125-14-297583.txt   210393
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 141018872
SIC: 2836 Biological Products, (No Diagnostic Substances)